LP-184 is under clinical development by Starlight Therapeutics and currently in ...
Johnson & Johnson (J&J) has received the US FDA and EC approvals for SIRTURO (be...
Moderna has received a grant of $176m through the RRPV Consortium to expedite th...
Academic institutions and nonprofit organisations are jumping in to save access ...
Leqembi will now face a challenger as donanemab enters the market under the bran...
Beacon’s lead candidate AGTC-501 is currently in a Phase II/III clinical trial f...
The takeover, which includes the candidate felzartamab, for immune-mediated dise...
Emergent will supply vaccines for anthrax and smallpox, VIV for treating smallpo...
The EMA has granted approval to Sanofi's Dupixent for adults with uncontrolled c...
GSK and CureVac have announced the restructuring of their existing partnership i...
Metal contamination in pharmaceutical products is a huge problem. Detection and ...
Idrebormilast is a small molecule commercialized by Pfizer, with a leading Phase...
Rezatapopt is a small molecule commercialized by PMV Pharmaceuticals, with a lea...
Osivelotor is a small molecule commercialized by Pfizer, with a leading Phase II...
Suzetrigine is a small molecule commercialized by Vertex Pharmaceuticals, with a...
Atirmociclib is a small molecule commercialized by Pfizer, with a leading Phase ...
